
Xiaolu Zhu
Articles
-
May 20, 2024 |
onlinelibrary.wiley.com | Xiaolu Zhu |Peking Beijing |Feifei Tang |Wenjing Yu
1 INTRODUCTION Despite the success of low-risk acute promyelocytic leukaemia (APL) in the all-trans retinoic acid (ATRA) plus arsenicals era, several important clinical issues continue to account for treatment failure including early death (ED) and disease relapse.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →